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Abstract
Background: Rating scales like the visual analogue scale, VAS, and the verbal rating scale, VRS, are often used
for pain assessments both in clinical work and in research, despite the lack of a gold standard. Interchangeability
of recorded pain intensity captured in the two scales has been discussed earlier, but not in conjunction with taking
the influence of pain etiology into consideration.
Methods: In this cross-sectional study, patients with their pain classified according to its etiology (chronic/
idiopathic, nociceptive and neuropathic pain) were consecutively recruited for self-assessment of their actual pain
intensity using a continuous VAS, 0–100, and a discrete five-category VRS. The data were analyzed with a non-
parametric statistical method, suitable for comparison of scales with different numbers of response alternatives.
Results: An overlapping of the VAS records relative the VRS categories was seen in all pain groups. Cut-off
positions for the VAS records related to the VRS categories were found lower in patients with nociceptive pain
relative patients suffering from chronic/idiopathic and neuropathic pain. When comparing the VAS records
transformed into an equidistant five-category scale with the VRS records, systematic disagreements between the
scales was shown in all groups. Furthermore, in the test-retest a low percentage of the patients agreed to the
same pain level on the VAS while the opposite hold for the VRS.
Conclusion: The pain intensity assessments on VAS and VRS are in this study, not interchangeable due to overlap
of pain records between the two scales, systematic disagreements when comparing the two scales and a low
percentage intra-scale agreement. Furthermore, the lower VAS cut-off positions relative the VRS labels indicate
different meaning of the rated pain intensity depending on pain etiology. It is also indicated that the scales have
non-linear properties and that the two scales probably have different interpretation. Our findings are in favor of
using the VRS in pain intensity assessments but if still the VAS is preferred, the VAS data should be analyzed as
continuous using statistical methods suitable for ordinal data. Furthermore, our findings indicate a risk to over or
under estimate the patient's perceived pain when interpreting condensed VAS data.
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Background
The assessment of perceived pain is necessary in the clini-
cal setting for diagnosis and choice of treatment but also
for the evaluation of treatment efficacy in a research con-
text. The multidimensional pain sensation involves the
subjective evaluations of the sensory aspect like intensity,
the affective component such as unpleasantness and the
cognitive aspect like thoughts related to the condition.
The pain intensity, also mentioned as the severity of pain,
is probably the most commonly assessed dimension of
pain [1].
The level of personal pain experience is only possible to
determine indirectly by self-reported ratings often by
using uni-dimensional pain rating scales that may be used
for various dimensions of pain. The most commonly used
scales, both in ordinary clinical work and in research, are
the continuous visual analogue scale, VAS, and discrete
categorical scales like the verbal rating scale, VRS, and the
numerical rating scale, NRS. Although widely used, there
is so far no support for a rational choice of one of these
scales [2] even though NRS has previously been recom-
mended as an outcome measure for chronic/idiopathic
pain clinical trials [3]. In the absence of gold standard
there is a need to study to what extent the individual
scores captured on one pain scale are interchangeable
with the individual scoring on another pain scale, i.e. the
quality of the intra-individual assessments.
On group level, the pain assessments on VAS and VRS
have been variably reported as highly inter-correlated
[4,5] but also as not being interchangeable [6,7] for exam-
ple due to overlapping VAS records when related to the
categories of the VRS. This overlap is obvious, albeit not
highlighted, from the results of several studies related to
various clinical conditions [8-10] though not in conjunc-
tion with taking the etiology or mechanism of pain classi-
fication into consideration. A similar overlap was also
demonstrated when comparing VAS and NRS of pain in
rest and during activity in different pain conditions [11].
To provide a rational treatment approach, classification of
pain is also recommended according to its etiology
[12,13] or, if possible, to its mechanism [14]. Since the
pain experience is uncertainly related to the extent of
injury or stimulation [15], the perceived pain may have
linear or non-linear properties [16].
The purpose of this study was to evaluate the quality of the
intra-individual assessments of self-reported pain inten-
sity on a continuous VAS (0–100) and a discrete five-cate-
gory VRS, in patients with pain. The patients were
separately described in groups of pain etiology. The eval-
uation includes inter-scale concordance, implying to
which extent the assessment on one scale can be replaced
by the assessment on the other, without change of the
result. The consistency between the scales were also eval-
uated when continuous VAS assessments were trans-
formed into discrete scales defined by equidistant cut-off
positions as well as by unbiased cut-off positions relative
the VRS data. The intra-individual assessment stability of
both scales is evaluated by test-retest reliability. A statisti-
cal approach will be applied that is suitable for all types of
data having at least an ordered structure, though distances
and magnitude are unknown [17].
Methods
Subjects
Outpatients with diagnosed pain conditions were consec-
utively recruited from the rehabilitation medicine clinic
and the spinal cord injury out patient department at the
Karolinska University Hospital, in Stockholm. The assess-
ments were conducted in accordance with the declaration
of Helsinki and the patients gave their informed consent
to participate. The study was approved by the Ethics Com-
mittee of Karolinska University Hospital (dnr 03–162).
The patient's pains, in general located to, and/or projected
to the musculoskeletal system, were previously classified
according to its etiology by their physicians into –
chronic/idiopathic pain, nociceptive or neuropathic pain
[12,13]. The chronic/idiopathic pain was described as
generally persistent, distributed without neuro-anatomi-
cal distribution and present without noxious stimulus
which could result from abnormal processing of normal
input in the central nervous system. The criteria of nocic-
eptive pain can be described as a response to activation of
damaged tissue where the local pain intensity increases
during movement or loading of the affected tissue. The
characteristic features of neuropathic pain were among
the patients in this study, pain located at and/or below the
level of the damaged neural structure, i.e. in this case the
spinal cord injury, in an area with altered sensibility and
persistent or spontaneous pain unrelated to loading.
All patients were also asked about their prescription of
analgesics and whether they had consumed any pain kill-
ing drugs on the day of assessment.
Study design and pain rating scales
This is a cross-sectional study in the sense that the three
pain etiology groups will be described separately. In order
to avoid assessment bias the two scales for self-rated pain
intensity were administrated to the patients in random
order 30 minutes prior to their appointment, scheduled in
advance, with their physician. The scales were a continu-
ous, horizontal, visual analogue scale, VAS, (0–100) with
the anchor points, "no pain" and "worst possible pain "
respectively and, a discrete, five-category, verbal rating
scale, VRS, with the eligible alternatives – no pain (0),BMC Medical Research Methodology 2005, 5:31 http://www.biomedcentral.com/1471-2288/5/31
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mild (1), moderate (2), severe (3), worst possible pain
(4), [see Additional file 1].
Although the pain rating scales were, per se, familiar to
almost all patients, they were again informed about their
use and encouraged to try them out prior to the real
assessments. Thereafter, the patients were asked to rate
their actual pain intensity by marking a level on the scales
corresponding to their experienced pain intensity level. In
case of not perceiving pain in rest, which was the case
among some of the patients with nociceptive pain, the
engaged tissue was loaded by isometric muscle contrac-
tions or by testing the respective joints active/passive
range of movement in order to provoke the pain and
thereby be able to rate any actual pain. The VAS was pre-
sented on paper sheets and the VRS on an electronic diary
(Clinitrac®). The assessment on the electronic diary was
transformed to a code-locked data base.
The assessment procedure was repeated for the intra-indi-
vidual stability evaluation. In the analyses the pain assess-
ments on the VAS were assigned the numeric values 0
through 100 yielding 101 ordered positions.
Statistical methods
The mean value and standard deviation (SD) were calcu-
lated for age. Frequency distributions were shown for
patients' duration of pain and the use of different analge-
sics. The median and range (minimum to maximum)
were used to describe the ordinal data of self-rated pain.
The statistical method used is designed for comparing
scales with different numbers of possible response alter-
natives [6,7]. As each individual assessed their perceived
pain on two scales the data set consists of paired data,
(VAS, VRS). Interchangeability between scales with differ-
ent numbers of response categories requires a high level of
order-consistency, i.e. lack of overlapping of the records
on one scale relative the other. A possible presence of
overlapping was described and evaluated from scatter and
line plots. For example, the pairs (34, no pain), (34, mild
pain) and (34, moderate pain) are overlapping. The two
pairs (43, mild pain) and (48, moderate pain) represent
ordered pairs and the two pairs (43, severe pain) and (48,
moderate pain) exemplify disordered pairs. The number
of disordered pairs, out of all possible different pairs, was
calculated and defines the measure of disorder, D [6,7].
The level of order-consistency is defined by the coefficient
of monotonic agreement, MA, which can be calculated by
MA = 1-2D and ranges from -1 to 1.
In order to describe the correspondence between con-
densed VAS data and the VRS categories, the continuous
VAS assessments were transformed to a discrete five-cate-
gory scale in two ways; the cut-off positions being defined
unbiased relative the VRS assessments, and being defined
equidistantly, respectively.
The cut-off positions of the visual analogue line, which
define a discrete VAS that is unbiased to the VRS data, are
constructed by pairing off the two sets of frequency distri-
bution to each other and by identifying the cut-off posi-
tions in VAS that corresponds to the change in category of
the VRS. This procedure creates pairs that are in complete
order, MA = 1. Thus the condensed discrete scale based on
the continuous VAS records will, under this circumstance,
show a total order consistency and no systematic disagree-
ment (be unbiased) relative the VRS. Another approach is
to condense the continuous VAS records into an equidis-
tant five-category scale that is to be compared with the
five-category VRS.
A high level of order consistency between scales with the
same number of categories, in our case the condensed VAS
and the VRS, requires a high percentage agreement (PA,
%) and a lack of systematic disagreement (bias) of the
pairs of data. The frequency distribution of the pairs of
data was evaluated by means of square (5 × 5)-contin-
gency tables. The proportion of identical pairs defines the
PA. A presence of different frequency distributions, also
called marginal distributions, indicate a presence of sys-
tematic disagreement (bias), which means that the catego-
ries of the two scales have different interpretations and
are, thereby, not regarded as interchangeable. Two meas-
ures of systematic disagreement were calculated; the rela-
tive position, RP, and the relative concentration, RC, with
possible values ranging from -1 to 1 [16]. The RP esti-
mates the difference between the probability of the pain
assessments on one scale being shifted towards higher cat-
egories relative to the other scale and the probability of
the assessments on one scale being shifted towards lower
categories relative to the other. The RC estimates the dif-
ference between the probability of the pain assessments
on one scale being concentrated relative to the other and
vice versa.
The stability of intra-individual assessments was calcu-
lated from test-retest pairs of data and a high level of sta-
bility requires high level of intra-individual agreement,
PA, and a lack of systematic disagreement, which means
zero or negligible RP and RC values.
The software package of Statistica, 6.0 was used for
descriptive statistics and SYSRAN 1.0 for Matlab 6 was
used to calculate D, MA, RP, RC and the corresponding
95% confidence intervals for the RP and RC.
Results
Eighty patients, (mean age 42.8; SD 12.7 years), recruited
from the three pain groups, participated in the study andBMC Medical Research Methodology 2005, 5:31 http://www.biomedcentral.com/1471-2288/5/31
Page 4 of 9
(page number not for citation purposes)
rated their actual pain intensity. All were capable to inde-
pendently managing the pain assessment instruments.
Analgesic drugs were most frequently prescribed to the
patients in the chronic/idiopathic and neuropathic pain
groups. On the day for pain intensity assessments, fewer
patients had consumed analgesic drugs than what was
prescribed, table 1.
The results of the first assessments were chosen for inter-
scale comparison and both assessments were used for the
test of intra-scale stability.
The median levels of rated pain intensity on the VAS were:
chronic/idiopathic pain, 59 (range, 12 to 96); nociceptive
pain, 25 (range, 4 to 76); neuropathic pain 64 (range, 18
to 100), fig 2. The corresponding median levels of VRS rat-
ings were moderate (2) for all subgroups but with differ-
ent ranges: chronic pain ranged from mild pain (1) to
worst possible pain (4); nociceptive pain ranged from
mild pain (1) to severe pain (3); neuropathic pain ranged
from mild pain (1) to worst possible pain (4), figure 1.
Inter-scale comparison, continuous VAS versus VRS
Overlapping VAS records relative the VRS categories mild,
moderate, and severe pain were seen in all groups in this
study, figures 1, 2, indicating that rated pain intensity
labeled as e.g. moderate and severe according to the VRS
corresponds to any possible value from 26 to 66, and
from 41 to 92 respectively on the VAS in chronic/idio-
pathic pain patients.
The measured level of concordance, monotonic agree-
ment (MA), was found to be similar in all groups of etiol-
ogy (chronic/idiopathic pain, MA = 0.89; nociceptive
pain, MA = 0.87; neuropathic pain, MA = 0.88), revealing
a difference between the ordered and disordered pairs of
assessments.
Inter-scale comparison, discrete VAS versus VRS
The cut-off positions of the discrete five-category VAS,
unbiased to the VRS, were similar in the chronic/idio-
pathic and neuropathic pain groups (12, 31, 66, 90 and
18, 19, 65, 99 respectively) while cut-off positions in the
nociceptive pain group were lower (4, 22, 51, 77), figure
3. The different cut-off positions indicate that the rated
pain intensity could have different meaning depending
on pain etiology. Figure 3 also shows the inconsistencies
between the scales when the VAS records were divided
into a five equidistant category scale. For example a
Table 1: Demographic data of pain patients.
Pain etiology group
Chronic/idiopathic, n = 30 
(women, n = 13)
Nociceptive, n = 31 
(women, n = 15)
Neuropathic, n = 19 
(women, n = 8)
Age, mean (SD), years 42.8 (10.6) 40.0 (14.2) 47.3 (12.7)
Duration of pain, months, n (%)
0–3 8 (26) 1 (5)
4–6 6 (19)
7–12 5 (16) 3 (16)
> 12 30 (100) 12 (39) 15 (79)
Patients prescribed with analgesics, n (%) 26 (87) 3 (10) 17 (89)
Patients consuming analgesics the day of assessments, n (%) 11 (37) 3 (10) 14 (74)
Joint distribution of rated pain intensity on the continuous  VAS versus the discrete VRS in patients with chronic, nocice- ptive and neuropathic pain, respectively Figure 1
Joint distribution of rated pain intensity on the continuous 
VAS versus the discrete VRS in patients with chronic, nocice-
ptive and neuropathic pain, respectively.
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patient rating the perceived pain as mild, could be labeled
as no pain in the equidistant VAS. This phenomenon was
seen in all groups.
The observed inconsistencies between the scales imply
lack of interchangeability which were confirmed by the PA
(ranging from 29% to 60%) and the measures of system-
atic disagreement, especially in concentration (RC), figure
4a–b, table 2.
Test-retest reliability, intra-scale stability
In the two repeated VAS assessments a low proportion of
the patients, 11% to 26%, in the three groups recorded the
same pain level, and 87% to 100% of the patients
recorded the same level in the repeated ratings on the VRS,
table 3.
Discussion
The results of this study showed overlapping records
between the two scales and a comparable level of inter-
scale discordance in all pain etiology groups. For the VAS
data condensed into a discrete scale unbiased the VRS, the
cut-off positions corresponding to the labels – no pain,
mild, moderate, severe and worst possible pain – were
similar in patients with chronic/idiopathic and neuro-
pathic pain but lower in the patients with nociceptive
pain, indicating influence depending on pain etiology.
For the equidistant discrete VAS data a systematic disa-
greement especially in concentration was found relative
the VRS levels which means lack of interchangeability.
Similar consequences of condensing continuous VAS data
into discrete levels have been found elsewhere [6,7] but is
not discussed in the findings of Jensen et al. [18].
Line plots of recorded rated pain intensity on continuous VAS, 0–100 and on the VRS relative the VAS, for the three pain eti- ology groups respectively Figure 2
Line plots of recorded rated pain intensity on continuous VAS, 0–100 and on the VRS relative the VAS, for the three pain eti-
ology groups respectively.
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In the test-retest of the two scales, a low percentage agree-
ment were seen in assessments on VAS through all pain
categories, where only 11 to 26% of the patients agreed to
the same level, while a high percentage agreement were
found in assessments on VRS where 87 to 100% of the
patients agreed to the same level. No systematic disagree-
ment was found in test-retest of either scale. The results of
this study therefore imply that the records of self-assessed
pain intensity on the VAS and the VRS, performed by the
same individuals, are not interchangeable, possibly
requiring different interpretation, and that the pain inten-
sity assessments on the VAS do not have linear properties.
This confirms the results of Svensson and Svensson et
Berndtson [6,7,9] in evaluating the use of rating scales for
the assessment of subjective variables.
The lack of operational definition of the VAS can possibly
induce insecurity on how to relate to the continuous VAS
line, thereby contributing to the low percentage agree-
ment of the individual repeated records. The principles of
pain classification, that are continuously discussed, could
also contribute to the variable results of the present study.
Due to its complexity, the pain classifications are not eas-
ily executed and there may be unidentified differences
between the different pain etiologies, i.e. chronic/idio-
pathic, nociceptive and neuropathic pain. For instance,
Line plots of VAS records condensed into discrete five-category scales relative the VRS – totally ordered (unbiased) and equi- distant for the three pain etiology groups respectively Figure 3
Line plots of VAS records condensed into discrete five-category scales relative the VRS – totally ordered (unbiased) and equi-
distant for the three pain etiology groups respectively.
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the chronic/idiopathic pain is not recommended to be
regarded as a single entity [13] since it may include several
etiologies and, furthermore, may be referred to as a dis-
ease on its own rights [19]. The associated chronic pain is
probably not directly related to their initial injury or dis-
ease condition, but rather to secondary changes, including
ones that occur in the pain detection system itself [14,19].
Also the diversity in neuropathic pain conditions is dis-
cussed in terms of its appearance as "definite, possible or
unlikely" [20] and, besides the existence of varying
degrees of 'neuropathic' components in chronic pain con-
ditions [20,21]. According to the classification by Rasmus-
sen et al. [20], the patients in this study that were classified
as neuropathic, could with most certainty be considered
as definite since the etiology is spinal cord injury. The
patients suffering from chronic pain may, on the other
hand, include some degree of possible neuropathic pain.
The pain experience may also be influenced by multiple
a–b Contingency tables of frequency distribution of discrete VAS records relative the VRS on a) the unbiased five-category  VAS (v0–v4) relative the VRS (0–4) and b) the equidistant five category VAS (v0–v4) versus the discrete five category VRS (0– 4) in patients with nociceptive pain Figure 4
a–b Contingency tables of frequency distribution of discrete VAS records relative the VRS on a) the unbiased five-category 
VAS (v0–v4) relative the VRS (0–4) and b) the equidistant five category VAS (v0–v4) versus the discrete five category VRS (0–
4) in patients with nociceptive pain. Agreeing pairs of data are shown in the grey shaded main diagonal.
Table 2: Inter-scale comparisons of five categories VAS versus VRS.
Unbiased VAS vs VRS Equidistant VAS vs VRS
Pain etiology group PA (%) MA PA (%) MA RP (95% CI) RC (95% CI)
All, n = 81 73 0.93 44 0.96 0.18
(0.07 to 0.28)
0.43
(0.33 to 0.53)
Chron/idiop,
n = 30
67 0.95 60 0.99 0.06
(-0.07 to 0.20)
0.27
(0.12 to 0.42)
Nociceptive,
n = 31
77 0.90 29 0.91 0.44
(0.27 to 0.61)
0.56
(0.29 to 0.83)
Neuropathic,
n = 19
58 0.86 42 0.96 -0.02
(-0.25 to 0.21)
0.36
(0.08 to 0.64)
Chron/idiop = Chronic/Idiopathic; PA = Percentage Agreement; MA = Monotonic Agreement; RP = Relative Position; RC = Relative 
Concentration; CI = Confidence Interval
a)
Unbiased five-
category VAS 
v0 v1 v2 v3 v4
4 0
31 5 6
23 9 12
1 10 21 1 3
V
R
S
0 0
01 3 1 26 031
Equidistant five- 
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v0 v1 v2 v3 v4
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V
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S
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other factors such as gender, cultural conditioning, expec-
tations, social contingencies, mood state, and perceptions
of control. In a future however, the principles of pain cat-
egorization is hypothesized to be based on the pain mech-
anism [14].
There is a controversy in the literature regarding which rat-
ing scale being most sensitive to change. Because verbal
scales usually have few steps, they are considered to be less
sensitive than VAS. Breivik and collaborators [8] reported
that assessments of acute pain with a four category VRS,
was less sensitive than VAS, 0–100, while VAS and an
eleven category NRS, showed similar sensitivity and was
recommended to be adopted based on subjective prefer-
ence. Interestingly the VAS scores were, in the same study,
reported as being possible to be classified into any of the
four VRS categories. Furthermore, the shortcomings of
using the VRS has been described as that the patient is
forced to translate a feeling into a predefined word that
possibly not fit exactly to the patient's experience and,
also, that the same word does not necessarily mean the
same thing to each patient [4]. On the other hand, a recent
study showed that a VRS was superior to the VAS, NRS,
verbal numerical rating scale and a faces pain scale consid-
ering internal consistency reliability, sensitivity, and
preferred by adults [22]. Furthermore, a preference for
VRS over VAS was found by Clark and collaborators [23]
when 113 patients were asked, and the VRS is recom-
mended for clinical trials due to it easiness to learn how
to handle and to interpret its changed score [24].
Consistent with the findings of Ponce de Leon et al. [25],
we found a greater intra-individual agreement using the
VRS than using the VAS for assessment of subjective phe-
nomena such as pain. The reason for this response may be
due to the use of verbal descriptors or the use of only five
categories, but also possibly due to that subjective percep-
tions, such as pain, could be more easily expressed in
words than by a mark on a continuous line without oper-
ational definition or by numbers. Different expressions
such as faces and images could also serve as response alter-
native of perceived pain level.
Based on the results of this study, numerals in pain rating
seem meaningless since rated moderate pain intensity
could be presented on the VAS with a range from 22–65
though there are suggestions of regarding ratings more
than 30 mm on VAS as probable moderate and ratings
more than 54 mm as probable severe when using a 4-
point categorical scale [26].
Limitation of this study
One limitation of our study could be the small number of
patients and the possible presence of various pain etiolo-
gies in some individuals. Our results refer to rated, indi-
vidual actual pain intensity of patients suffering from pain
of different etiologies and cannot be generalized to other
situations.
Conclusion
The records of actual pain intensity on the VAS and the
VRS are, in this study, not interchangeable in any of the
pain etiology groups due to overlap of pain records
between the two scales, systematic disagreements when
comparing the two scales and a low percentage intra-scale
agreement. Furthermore, the lower VAS cut-off positions
relative the VRS labels indicate different meaning of the
rated pain intensity depending on pain etiology. The
results also indicate that the scales have non-linear prop-
erties and that the two scales probably have different
interpretation. Our findings are in favor of using the VRS
in pain intensity assessments but if still the VAS is pre-
ferred, the VAS data should be analyzed as continuous
using statistical methods suitable for ordinal data. Fur-
thermore, our findings indicate a risk to over or under esti-
mate the patient's perceived pain when interpreting
condensed VAS data.
Table 3: Test of intra-scale stability in VAS (0–100) and VRS.
VAS VRS
Pain etiology group PA (%) RP (95% CI) RC (95% CI) PA (%) RP (95% CI) RC (95% CI)
All, n = 81 20 0.01
(-0.03 to 0.04)
-0.02
(-0.08 to 0.05)
94 0.03
(-0.01 to 0.06)
0.04
(-0.01 to 0.08)
Chron/idiop,
n = 30
20 -0.05
(-0.12 to 0.01)
-0.07
(-0.18 to 0.03)
97 0.02
(-0.02 to 0.07)
-0.01
(-0.04 to 0.02)
Nociceptive,
n = 31
26 0.07
(-0.004 to 0.15)
0.03
(-0.05 to 0.12)
87 0.06
(-0.04 to 0.16)
0.11 
(-0.01 to 0.22)
Neuropathic,
n = 19
11 0.04
(-0.06 to 0.14)
-0.05
(-0.19 to 0.10)
100 0.00 0.00
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Supplementary Figure 1a-b. The two rating scales used for self-assessed 
actual pain intensity. In the analysis, the VAS and the VRS assessments 
were assigned the numeric values 0 through 100 and 0 through 4 respec-
tively, each with the anchor points "no pain" and "worst possible pain" 
respectively.
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